Webinar presentation: Information session on the revised evidence guidelines for listed medicines, 23 March 2022

Disclaimer

These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.

The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.

Presentation

• Presented by: : Diane Wilkinson - Therapeutic Goods Administration
• Presented at: Online webinar
• Presentation date: Wednesday 23 March 2022
• Presentation summary: The TGA providing an overview of the revised evidence guidelines for listed medicines.

• Presentation: Information session on the revised evidence guidelines for listed medicines, 23 March 2022 (pdf,1.6Mb)